Related to Protecting Newborns from RSV by Immunizing Moms-to-Be

• Opinion: A Stem of Hope for Cancer Treatments
  Evidence mounts in favor of therapies targeting cancer stem cells.
  
• AIDS Vaccine Development Will Rely on Blind Guesses—At Least for Now
  Past failures from companies jumping on the T-cell bandwagon have borne out the complexity of the virus and prompted renewed thinking.
  
• What Comes After Dendreon’s Provenge?
  Success of prostate cancer vaccine has ushered in a wave of autologous vaccine development.
  
• Will a Nonautologous Cancer Vaccine Be the Next to Make It Through Approval?
  In the race to mimic Dendreon’s success with Provenge, off-the-shelf products make for attractive opportunities.
  
• Exploring New Ways to Get at Old Bacterial Targets to Combat Resistant Strains
  Arsenal must include not just souped-up me toos but also some brand new compounds.
  
• Does Clinical Success Mean Commercial Success for Cancer Vaccines?
  Getting insurers to pay for immunotherapies and keeping doctors more informed are key to market growth.
  
• Vaccine Isotype Seems to Affect Clinical Outcome in Blood Cancer Trials
  New results presented at ASH will impact production of autologous immunotherapies.
  
• Policy Makers, Regulators Are Trying to Fortify Focus on Treating Superbugs
  Legislation and FDA rules have been slow to come, but all voice a sense of urgency.
  
• CMOs Capitalizing on Experience to Develop Their Own Therapeutics
  A few pioneering contract manufacturing organizations are testing the drug development waters.
  
• For New HIV Test, There’s No Place Like Home
  OTC test could decrease transmission by increasing diagnosis and subsequent treatment.
  
• Why The AIDS Vaccine Remains Elusive
  Virus’ variability and ability to integrate with host DNA are two major hurdles.
  
• Getting Cancer Immunotherapeutics Approved
  It’s not just the FDA standing in the way.
  
• Slaying the Fungus Among Us
  Meningitis outbreak aggravates concerns about amphotericin B, as study begins shedding light on how the antifungal works.
  
• With GAIN, Less Pain
  Antibiotic drug developers welcome incentives, though cost, rules remain a challenge.
  
• Building a Self-Destructive Mosquito
  Genetically modified mosquitos could be a way to curb the spread of dengue fever in Florida.
  
• 10 Predictions That Will Transform Healthcare
  Peer into GEN's crystal ball for a glimpse of what's to come.
  
• Bird Flu Back Again?
  H7N9 has killed six people so far. Find out what’s being done about it.
  
• Literature Review: Bacteria Reprogram Host Cells in Order to Survive and Spread
  Researchers describe how leprosy bacilli can change Schwann cells to stem cell-like cells to promote infection.
  
• Not Quite 1918, but Flu Still Deadly
  Authorities and manufacturers look ahead to new vaccines and immunization efforts while scrambling to deal with spot shortages.